Skip to main content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 23-24/2021

20.10.2021 | review article

Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic

A review

verfasst von: Dr. Achim Leo Burger, Christoph C. Kaufmann, Bernhard Jäger, Edita Pogran, Amro Ahmed, Johann Wojta, Serdar Farhan, Kurt Huber

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2021

Einloggen, um Zugang zu erhalten

Summary

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), puts a heavy strain on healthcare systems around the globe with high numbers of infected patients. Pre-existing cardiovascular disease is a major risk factor for a severe clinical course of COVID-19 and is associated with adverse outcome. COVID-19 may directly exacerbate underlying heart disease and is frequently aggravated by cardiovascular complications, including arterial and venous thromboembolic events, malignant arrhythmia and myocardial injury. In addition to these direct cardiac manifestations of COVID-19, patients with cardiovascular disease face further indirect consequences of the pandemic, as the respective resources in the healthcare systems need to be redirected to cope with the high numbers of infected patients. Consecutively, a substantial decrease in cardiac procedures was reported during the pandemic with lower numbers of coronary angiographies and device implantations worldwide. As a consequence an increased number of out-of-hospital cardiac arrests, late-comers with subacute myocardial infarction and of patients presenting in cardiogenic shock or preshock were observed. Maintenance of high-quality cardiac care by avoiding a reduction of cardiac services is of utmost importance, especially in times of a pandemic.
Literatur
6.
Zurück zum Zitat Auer J, Huber K. COVID-19 – Kardiologische Aspekte. J Kardiol Austrian J Cardiol. 2020;27(5):152–5. Auer J, Huber K. COVID-19 – Kardiologische Aspekte. J Kardiol Austrian J Cardiol. 2020;27(5):152–5.
43.
Zurück zum Zitat Oldenburg J, Klamroth R, Langer F. Aktualisierte Empfehlungen zur Thromboseprophylaxe bei SARS-CoV‑2 (COVID-19). 2020. Oldenburg J, Klamroth R, Langer F. Aktualisierte Empfehlungen zur Thromboseprophylaxe bei SARS-CoV‑2 (COVID-19). 2020.
45.
Zurück zum Zitat Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859–65. https://​doi.​org/​10.​1111/​jth.​14929. CrossRefPubMed Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859–65. https://​doi.​org/​10.​1111/​jth.​14929. CrossRefPubMed
67.
Zurück zum Zitat Burger AL, Kaufmann CC, Jaeger B, Wojta J, Farhan S, Huber K. Verlauf undTherapie kardiovaskulärer Erkrankungen im Rahmen der Covid-19-Pandemie. J Kardiol Austrian J Cardiol. 2021;28:1–2. Burger AL, Kaufmann CC, Jaeger B, Wojta J, Farhan S, Huber K. Verlauf undTherapie kardiovaskulärer Erkrankungen im Rahmen der Covid-19-Pandemie. J Kardiol Austrian J Cardiol. 2021;28:1–2.
77.
Zurück zum Zitat Mühlberger V, Alber H, Bonner G, et al. Herzkathetereingriffsdaten im COVID-Pandemiejahr 2020 im Vergleich zu 2019 aus dem österreichischen ANCALAR-Register. J Kardiol. 2021;28:5–6. Mühlberger V, Alber H, Bonner G, et al. Herzkathetereingriffsdaten im COVID-Pandemiejahr 2020 im Vergleich zu 2019 aus dem österreichischen ANCALAR-Register. J Kardiol. 2021;28:5–6.
99.
Zurück zum Zitat Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2018;39(2):119–77. https://​doi.​org/​10.​1093/​eurheartj/​ehx393. CrossRefPubMed Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2018;39(2):119–77. https://​doi.​org/​10.​1093/​eurheartj/​ehx393. CrossRefPubMed
Metadaten
Titel
Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic
A review
verfasst von
Dr. Achim Leo Burger
Christoph C. Kaufmann
Bernhard Jäger
Edita Pogran
Amro Ahmed
Johann Wojta
Serdar Farhan
Kurt Huber
Publikationsdatum
20.10.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 23-24/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01956-2

Weitere Artikel der Ausgabe 23-24/2021

Wiener klinische Wochenschrift 23-24/2021 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungstipps